PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE. (23rd June 2022) - Di Folca, S.; Marafioti, V.; barbato, S.; Avilia, S.; Grimaldi, F.; Severino, A.; Picardi, M.; Luciano, L.; Battipaglia, G.; Pane, F.